Premium
FcγRIIB, a new checkpoint to halt alloreactive memory T cells
Author(s) -
Cravedi Paolo
Publication year - 2020
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.15854
Subject(s) - medicine , immunology , neuroscience , biology
Morris et al ( page 2206) newly report that memory CD8 + T cells, the main mediators of alloimmune response, express the checkpoint molecule FcγRIIB, which controls their activation and survival and therefore represents a potential therapeutic target for selective antirejection therapies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom